Personalized digital solutions for patients and their treatment challenges.

Pharmaceutical companies leverage our technology and expertise to launch evidence-based companion apps that support their products and their patients.

Discover our Platform
Select Partners
What we do

Empowering Pharma with Digital Companions for Enhanced Patient Support.

Our capabilities in agile software development and design combined with regulatory and market access expertise, ensures reduced time-to-market and frictionless deployment of safe, secure and effective companion apps that support patients beyond the pill.

More about the platform

Develop and deliver digital health products with ease.

Utilizing our established technology platform, we create tailored products designed to complement treatments and improve patient outcomes, across any indication.


Identify patient & HCP needs

Using qualitative interviews and other research methods to understand needs and pain points of patients and Health Care Professionals.


Select & tailor modules

Our platform consists of a range of modules helping to address the challenges faced by patients on and off treatment  — from adherence & side-effect management to mental health support.


User testing & validation

We evaluate the digital solution with patients and HCPs, collect feedback, and further tailor the modules to be meet their needs.


product 🚀

The solution is available on the market. Depending on needs, the product can be unregulated or regulated. We advocate starting small and building from there!

Ensure continuous patient engagement throughout a medicinal product's lifecycle.

Whether it's a digital patient support program or a regulated software-as-a-medical device (SaMD), digital companions can play a key role in facilitating the delivery of patient care and improving patient outcomes.

Selected Cases

Smoking cessation program treating nicotine addiction

Eila® is a 12-week program for the treatment of tobacco dependence. The product is currently undergoing clinical trial in Germany to provide an evidence-based, clinically validated, and personalized digital therapy to patients.

In collaboration with:


A digital health companion to increase quality of life for PF patients

This digital patient companion app provides treatment and support for patients with pulmonary fibrosis (PF), addressing low mood and anxiety. The product is currently undergoing clinical trial with results of the COMPANION study scheduled for release in January 2024.

In collaboration with:

News & Insights

The barriers to medication adherence and how digital health solutions can help overcome them

November 30, 2023

A Guide to Software as a Medical Device

November 29, 2023

New digital CBT-related CPT codes provide better incentives for psychologists and physicians to use digital health solutions

November 6, 2023
More Insights

Sign up for our industry insights

You've successfully signed up! 📫
⚠️ Oops! Something went wrong while submitting the form.

One platform for many indications.

We've simplified the process for companies to build indication-specific companion digital health solutions at scale. Reach out to learn more.

Get in touch